Home/Filings/4/0001859810-24-000005
4//SEC Filing

Milligan Sandra 4

Accession 0001859810-24-000005

CIK 0000926617other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 8:54 PM ET

Size

5.5 KB

Accession

0001859810-24-000005

Insider Transaction Report

Form 4
Period: 2024-11-12
Milligan Sandra
Interim CEO
Transactions
  • Award

    Stock option (right to buy)

    2024-11-12+25,00025,000 total
    Exercise: $0.84From: 2024-11-12Exp: 2034-11-12Common Stock (25,000 underlying)

Issuer

Aspira Women's Health Inc.

CIK 0000926617

Entity typeother

Related Parties

1
  • filerCIK 0001859810

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:54 PM ET
Size
5.5 KB